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Introduction 
In two previous papers I have 
presented a microcirculation-based 
unified theory of glucocorticoid ac-
tion (Schayer, 1964, 1967). To 
link the microcirculation to the 
major effects of these hormones 
requires the reasonable postulate 
that autonomous dilator responses 
result from a well-defined intrinsic 
mechanism, not from haphazard 
formation of "dilator metabolites" 
in other tissues. 
In this paper I will try to show 
how the proposed intrinsic dilator 
mechanism may, with due allow-
ance for a variety of modifying 
factors, underlie the dilator phases 
of reactive hyperemia, post-exercise 
hyperemia, hyperemia due to local 
warmth, autoregulation, vasomo-
tion, inflammation, and shock. 
These ideas are based on his-
tamine studies (Schayer, 1962, 
1963, 1966). However, since there 
is much misunderstanding about 
histamine, and since the theory can 
be largely developed without need 
to identify the dilator, this paper 
will be presented in two parts. First, 
interpretation of the above phe-
nomena in terms of an intrinsic di-
lator mechanism will be attempted. 
Second, evidence supporting his-
tamine as the dilator will be given. 
* Supported by USPHS Grant AM 
10155. 
MCV QUARTERLY 4(3): 101·106, 1968 
Requirements for an Intrinsic 
Dilator Mechanism 
The theory requires that the dila-
tor be continuously produced within 
microvascular smooth muscle cells 
by an inducible enzyme system, 
and that it act primarily on in-
tracellular "intrinsic" receptors. 
It is obvious that the micro-
circulation requires means for 
adaptation; this may be accom-
plished through alteration of en-
zyme activities. An intrinsic site of 
formation and action is supported 
by repeated failure to find dilator 
activity in fluids from dilated tis-
sues, and by the inability of any 
blood-borne substance to mimic 
natural dilator phenomena (Alex-
ander, 1963; Barcroft, 1963 ; Fol-
kow, 1949, 1964; Hilton, 1962; 
Zweifach, 1953) . 
Normal Distributio n of Intrinsic 
Dilator Molecules 
If a dilator were continuously 
synthesized within microvascular 
smooth muscle cells, it would be 
distributed into three distinct cate-
gories. ( 1) Intracellular: Some 
molecules would remain free in the 
cytoplasm of the smooth muscle 
cells. Since intrinsic receptors are 
stimulated, the intracellular concen-
tration of dilator would determine 
the magnitude of the dilator action. 
(2) Loosely Bound : As dilator 
molecules diffuse from the cell, 
some are loosely bound in the cell 
wall. ( 3) Extracellular: Dilator 
molecules reaching the lumen of 
the vessel will be washed away 
when blood is flowing, or accumu-
late if flow is blocked. Dilator mole-
cules in the blood stream, because 
of dilution or inactivation, are of 
no further significance. 
The autonomous microcircula-
tory phenomena listed in the Intro-
duction may all relate to this distri-
bution of dilator, or to modifica-
tions of it. 
Reactive Hyperemia 
When blood flow is mechani-
cally blocked, dilator molecules ac-
cumulate extracellularly. There fol-
lows a gradual increase in dilator 
concentration-first, in the cell wall, 
then intracellularly, and, finally, at 
intrinsic receptor sites. When the 
obstruction to flow is removed, 
muscle immediately relaxes to a de-
gree roughly proportional to the 
time of occlusion. As extracellular 
dilator is washed away, the intracel-
lular concentration gradually drops 
to normal. 
Interpretation of a number of 
key experiments relating to reac-
tive hyperemia is shown in Table 1. 
Vasomotion 
This periodic opening and clos-
ing of precapillary sphincters, said 
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to provide the most precise adjust-
ment of nutritive blood flow, may 
arise as follows: In the sphincter of 
a closed capillary, dilator accumu-
lates until relaxation occurs and 
blood flows. As extracellular dila-
tor molecules wash away, the in-
tracellular concentration gradually 
decreases. When constrictor forces 
(intrinsic "tone force" plus circulat-
ing constrictors) again predomi-
nate, the sphincter closes and the 
cycle is complete. 
The process of vasomotion can 
adjust to environmental require-
ments through an adaptive reset-
ting of the rate of intrinsic dilator 
synthesis . 
Post-Exercise Hyperemia 
The rapid production of heat in 
working skeletal muscle causes a 
local increase in tissue tempera-
ture. Intrinsic dilator production is 
immediately increased as a result 
of the temperature effect on en-
zymes. Precapillary sphincters im-
mediately open, thus initiating a 
"conducted vasodilatation" of ar-
terioles and arteries (Hilton, 1962). 
Presumably, moderate warming of 
a tissue by any means could have a 
similar effect; on the other hand, 
moderate cooling, by reducing in-
trinsic dilator production, could 
lead to the observed vasoconstric-
tion. 
Autoregulation 
In an isolated perfused tissue, a 
moderate increase in perfusion pres-
sure may increase flow through 
precapillaries, expedite washout of 
extracellular dilator, reduce the in-
tracellular concentration, cause 
sphincters to close more rapidly 
than they normally would, and 
thus increase resistance to flow. 
Conversely, a drop in perfusion 
pressure, by reducing the rate of 
dilator washout, would permit 
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TABLE 1 
Reactive Hyperemia in Muscle and Skin 
Compatibility of Intrinsic Dilator Mechanism with Experimental Findings 
Observation 
1. In isolated gastrocnemius of cat, 
30 seconds of artery occlusion 
and 30 seconds of maximal exer-
cise gave approximately the same 
increase in flow. However, after 
ischemia, flow subsided more 
quickly (Hilton, 1953). 
2. Reactive hyperemia in skeletal 
muscle is soon lost during per-
fusion with saline (Folkow and 
Lofving, 1956) . 
3. The longer the period of circu-
latory arrest, the greater the 
subsequent hyperemia. The in-
crease is mainly in duration of 
high flows, the peak value being 
relatively little increased (Patter-
son and Whelan, 1955) . 
4. Reactive hyperemia is most read-
ily demonstrated when a limb is 
warm. 
5. Reactive hyperemia is reduced if 
forearm is packed with blood 
during period of arrest (Duff, 
Patterson, and Whelan, 19 5 5) . 
6. In reactive hyperemia in the 
human leg, the rate of return of 
flow to initial levels was ex-
ponential (Dornhorst and Whe-
lan, 1953). 
7. From studying effect of reduced 
arterial pressure on reactive hy-
peremia and post-exercise hypere-
mia, Dornhorst and Whelan 
( 19 5 3) concluded that in both 
cases the vasodilation could be 
due to an intracellular metabo-
lite, the removal of which from 
the vessel wall is limited more 
critically by its diffusion gradient 
than by the rate of blood flow 
through the tissue lumen. 
8. In the forearm, after a five-
minute period of arrest, circula-
tion was released, but flow kept 
from rising above the resting 
level for an additional five min-
utes by compressing the brachia! 
artery. There was no reactive 
hyperemia when the artery was 
released (Blair, Glover, and Rod-
die, 1961). 
Comment 
1. In both cases, removal of excess 
dilator would depend on diffu-
sion from cell. However, after 
exercise, the rate of dilator syn-
thesis remains elevated until 
muscle temperature returns to 
normal. 
2. Production of an intrinsic dilator 
would be reduced as substrate 
and co-factors were removed. 
3. Accumulation of intrinsic dilator 
should relate to time of occlu-
sion. After the concentration 
required to cause maximal dila-
tion is reached, further accumu-
lation should, following release, 
prolong the period of high flow. 
4. Dilator synthesis is temperature 
dependent, and accumulation 
should occur more rapidly in a 
warm tissue. 
5. Packing would provide additional 
blood into which the dilator 
could diffuse ; intracellular ac-
cumulation would be reduced. 
6. The rate of loss of accumulated 
intrinsic dilator molecules should 
be roughly proportional to the 
number remaining and, therefore, 
exponential. 
7. The interpretation of Dornhorst 
and Whelan indicates that an in-
trinsic dilator best explains the 
findings of these experiments. 
8. Accumulated intrinsic dilator 
molecules can presumably diffuse 
from smooth muscle cells and be 
washed away by normal blood 
flows within five minutes. 
sphincters to remain open for a 
longer than normal period and 
thus reduce resistance to flow. 
Slowly Developing Dilator 
Responses 
If the mechanism for intrinsic 
dilator production is adaptive and 
is normally required for coping 
with minor, everyday, environ-
mental changes, then a marked in-
crease in production, caused by 
drastic local or systemic stimuli, 
could lead to the slowly developing 
microvascular dilatation observed 
in inflammation and shock, respec-
tively. 
Many authors have emphasized 
the similarities between inflamma-
tion and shock in this respect 
(Lewis, 1927; Moon, 1938) . Ac-
cording to Zweifach ( 1961), the 
development of shock seems to in-
volve progressive activation of a 
mechanism primarily concerned 
with local blood flow. 
As evidence that microvascular 
opening in inflammation and shock 
may be exaggerated manifestations 
of the normal intrinsic dilator 
mechanism, I cite the ability of this 
concept to provide a reasonable 
unification of glucocorticoid effects 
(Schayer, 1964a, 1967). If these 
hormones function by moderating 
the action of the microcirculatory 
dilator, their vital stress role and 
their anti-inflammatory effect could 
relate to antagonism of the in-
creased dilator influence in stress 
and inflammation; the metabolic 
effects of glucocorticoids could 
be derived from suppression of 
the normal dilator influence in 
vasomotion. The microcirculatory 
effect of glucocorticoids is their 
earliest known action; it is a ten-
dency to potentiate effects of vaso-
constrictors. The glucocorticoid-
intrinsic dilator relationship will be 
mentioned in a later section. 
In inflammation, endothelial 
changes also occur; this fact causes 
no difficulties in interpretation, pro-
vided that histamine is the intrinsic 
dilator (Schayer, 1964b). 
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Other Factors in Microcirculatory 
Dilatation 
Numerous substances or condi-
tions have been proposed to account 
for opening of small vessels in 
vasomotion, hyperemia, autoregula-
tion, inflammation, and shock. It 
is not denied that some may be of 
significance, particularly in brain, 
heart and kidney. However, pre-
occupation with a variety of mecha-
nisms seems to have led to the un-
satisfactory conclusion that there 
is no process inherent within micro-
vascular smooth muscle cells which 
is an obligatory participant in their 
response to every stimulus. I believe 
this process involves continuous 
production of traces of histamine, 
catalyzed by an inducible, environ-
ment-responsive form of histidine 
decarboxylase. Since many pitfalls 
may be encountered in the experi-
mental testing of this concept, the 
next section will be devoted to some 
of them. 
Comments on Experimental 
Testing of the Histamine-
Microcirculation Theory 
Histamine metabolism is a very 
complex field whose facts are often 
inaccessible to available experi-
mental procedures.. It is obvious 
that, if experimentation on his-
tamine led to unequivocal results, 
it should not have required 50 years 
to find a reasonable physiological 
role. 
The complexities of the field 
may be illustrated by considering 
the significance of quantitative 
analyses for histamine. 
The histamine content of a tis-
sue is a composite value which in-
cludes some or all of the following: 
(a) histamine ingested in the diet; 
(b) histamine formed in the in-
testine by bacteria and then ab-
sorbed; (c) histamine formed by 
another tissue, e.g., stomach, which 
produces relatively large amounts 
of histamine concerned with gastric 
secretion; ( d) histamine formed 
locally in mast cells and bound in. 
them, in inactive form, in enormous 
concentrations; ( e) histamine re-
leased from mast cells; (f) hista-. 
mine associated · with "non-mast 
cell" binding sites; (g) histamine 
of microvascular ongm which 
is "on its way out"; and (h) the 
relatively minute quantities of his-
tamine of microvascular origin still 
in a physiologically strategic posi-
tion. Obviously, there is no simple 
means of measuring (h) in the 
presence of the other pools, par-
ticularly when concentrations fluct-
uate in accordance with many fac-
tors, often poorly defined. Plasma 
histamine assays also give com-
posite values which are often mean-
ingless or misleading. 
Measurements of histidine de-
carboxylase activity are preferable, 
but here, too, there are problems. 
Histidine decarboxylase is found 
not only in microvascular cells but 
also in mast cells, stomach, and in 
certain specialized cells; each may 
vary in activity in response to its 
own specific stimuli and tend to 
obscure changes in microvascular 
histidine decarboxylase activity. 
Other difficulties in evaluating the, 
physiological role of histamine 
have been presented elsewhere 
(Schayer, 1963, 1966). 
For the most part, my findings 
on histamine have been confirmed 
in other laboratories (Graham, 
Kahlson and Rosengren, 1964; 
Graham and Schild, 1967; Johans-
son and Wetterqvist, 1963; Kahlson 
and Rosengren, 1964, 1968; Kahl-
son, Rosengren and Thunberg, 
1966; Pearlman and Waton, 1966). 
The single exception is experiments 
reported by Burton Altura (Altura 
and Zweifach, 1965a, b; 1967); he 
feels that some results are compati-
ble with the theory, while others are 
not. A detailed discussion of these 
experiments would require too 
much space, but I am confident 
that Altura's "negative" findings 
can be ·readily explained. Some of 
his experiments are too long and 
too complicated for clear interpre-
tation. In others, histamine levels 
of tissue determined in other lab-
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oratories under different conditions 
were used for evaluation. Still 
others are based on a misinter-
pretation of the significance of the 
theory. 
Experimental evidence and argu-
ments, which I believe provide im-
portant support for the histamine 
concept, are listed in the next sec-
tion. 
Evidence Supporting Histamine 
as an Intrinsic Microcirculatory 
Dilator 
Ability of Histamine to Mimic 
Natural Microcirculatory Dilation 
Histamine dilates microvascular 
smooth muscle; at higher concen-
trations it affects endothelial cells. 
It also can initiate reflex dilatation 
of arterioles. If histamine were 
formed within these cells, there is 
no evident reason why it could not 
underlie the phenomena under dis-
cussion. 
4,daptive Nature of Histamine 
Formation 
It is now known that adaptation 
often involves induction of enzymes 
in cell types which require them. 
Histidine decarboxylase is inducible 
to activity many times the normal 
level but, under certain circum-
stances, can be reduced to sub-
normal levels; its activity is clearly 
responsive to changes in internal 
and external environment. 
Vascular Locus of Histamine 
Formation 
Histidine decarboxylase is present 
in arteries and veins and can be ac-
tivated in them (Kahlson et al., 
1966; Schayer, 1962). These vessels 
contain no significant number of 
cells other than smooth muscle and 
endothelium. Further, the inducible 
form of histidine decarboxylase has 
been found in all tested tissues of 
the commonly studied species. This 
widespread distribution, a rigorous 
vequirement for a microvascular 
regulatory mechanism, has not been 
shown for any other inducible 
enzyme. 
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Autonomy of Histamine Production 
Small vessels can dilate due to a 
local mechanism; histidine decar-
boxylase activation can also be 
local. Neither process requires any 
known nervous or endocrine mech-
anism or the presence of any dis-
pensible tissue. 
Time Course of Increased 
Histamine Production 
Following a stimulus, local or 
systemic, histidine decarboxylase 
undergoes gradual activation, be-
coming first detectable in roughly 
30 to 60 minutes and reaching 
near-maximum activity in three to 
four hours. The duration of the ac-
tivated state depends on the persis-
tence of the stimulus; activity may 
return to near normal in 12 to 24 
hours (as after injection of cate-
cholamines) or may remain ele-
vated for at least ten days, the 
longest period tested (in turpen-
tine-injected rat paws) . The rate of 
activation is indistinguishable from 
the rate of development of the de-
layed phase of inflammation (Scha-
yer, 1963, 1964b; Spector and 
Willoughby, 1963) and, allow-
ing for constrictor effects of re-
leased catecholamines, activation 
parallels the gradual reopening of 
the small vessels in shock (Cham-
bers, Zweifach, and Lowenstein, 
1944; Schayer, 1961; Zweifach et 
al., 1957). 
Effect of Inhibition of Histidine 
Decarboxylase Activation 
The only drugs known to block 
activation of histidine decarboxy-
lase are inhibitors of protein syn-
thesis, e.g., puromycin, actidione 
( cycloheximide), and tenuazonic 
acid (Shigeura and Gordon, 1963). 
Actinomycin D, which inhibits syn-
thesis of RNA, and, thus, indirectly 
blocks activation of most known in-
ducible enzymes, fails to block his-
tidine decarboxylase activation 
(Schayer, 1968) . When these com-
pounds were tested on turpen-
tine inflammation in rat paw (a 
violent reaction virtually unaffected 
by cortisol or indomethacin), those 
drugs which blocked histidine de-
carboxylase activation also showed 
an extraordinarily great anti-in-
flammatory action. Actinomycin D 
failed to suppress either histidine 
decarboxylase activation or inflam-
mation; in fact, under certain ex-
perimental conditions, it enhanced 
both processes. Since this drug in-
directly blocks activation of many 
enzymes, the findings are strong 
evidence for a crucial role of his-
tamine in slowly-developing in-
flammation. 
Histamine and a Unified Theory 
of Glucocorticoid Action 
If it is postulated that the princi-
pal target of glucocorticoids is the 
microvascular smooth muscle cell 
and that these hormones function 
to reduce the dilator action of his-
tamine, one can derive a simple in-
terpretation for the stress function 
of glucocorticoids, their anti-in-
flammatory effect, and their wide-
spread influence on metabolic proc-
esses and body economy. This 
theory seems to be compatible with 
most of the major in vivo observa-
tions on glucocorticoid physiology 
and pharmacology (Schayer, 1964a, 
1967) . The histamine-microcircula-
tion theory may also help clarify 
the metabolic and developmental ef-
fects of thyroid hormone (Schayer, 
1969). 
Lack of an Alternative to Histamine 
If one accepts the existence of 
an intrinsic microcirculatory dila-
tor, it is necessary to consider the 
alternatives to histamine. To my 
knowledge, the only other sub-
stance seriously proposed as a 
"universal" dilator is bradykinin 
(Rocha e Silva, 1963). 
The case for bradykinin is ex-
tremely fragile, and I have listed 
many objections to it (Schayer, 
1963). Recently Webster, Skinner, 
and Powell ( 1967) have reported 
experiments which virtually elimi-
nate bradykinin as the dilator of 
skeletal muscle. The repeated fail-
ures to implicate bradykinin can 
not be attributed to an "intrinsic" 
site of formation, for the substrate 
of bradykininogen exists in plasma, 
not in cells. In contrast, free L-his-
tidine is abundant in all cells and 
all body fluids. 
Effect of Antihistamines on the 
M icrocirculation 
Topical application of antihis-
tamines to microcirculatory prep-
arations causes constriction of the 
small vessels; in this test antihis-
tamines behave like catecholamines 
(Altura and Zweifach, 1965a, b; 
Conard, 1951; Haley and Andem, 
1950; Haley and Harris, 1949). The 
constrictor effect is produced by 
antihistamines of many basic struc-
tures but is not shown by anti-
serotonin, anti-acetylcholine, or 
local anesthetic drugs as groups .. 
The effective concentrations of an-
tihistamines are high, but this is 
expected for antagonism of intrinsic 
histamine. 
The most recent work in this 
field has been done by Dr. Altura; 
he has concluded that antihista-
mines are direct vasoconstrictors 
(oral communication, 1968) and 
cites their contractile effect on 
uterine (Rocha e Silva, 1955) and 
bronchiolar (Hawkins, 1955) 
smooth muscle in vitro as evidence 
of direct action (Altura and Zwei-
fach, 1965b) . 
Since I reject this conclusion and 
regard the constrictor effect of an-
tihistamines as near proof for the 
reality of microvascular histamine, 
it is essential to consider these two 
conflicting views in detail. 
First, antihistamines are drugs 
of various structures which attach 
to histamine receptors and block 
virtually all histamine actions in 
vitro and in vivo; as a group they 
have no other identity. All antihis-
tamines have side effects, but these 
vary in kind and degree. 
Second, antihistamines have no 
catecholamine-like actions in vitro 
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(Goodman and Gilman, 1965). 
Third, since antihistamines are 
selected for their ability to occupy 
histamine receptors, it is not sur-
prising that many can release his-
tamine by displacing it from bind-
ing sites (Mota and da Silva, 1960). 
The stimulatory action of antihis-
tamines on uterine and bronchiolar 
smooth muscle is believed due to 
release of bound "intrinsic" his-
tamine (Rocha e Silva, 1955; Haw-
kins, 1955). This stimulatory effect 
resembles that of histamine, not 
catecholamines. The anomalous 
relaxing effect of histamine on rat 
uterus (Altura and Zweifach, 
1965a) mentioned by Altura is due 
to released catecholamines (Tozzi 
and Roth, 1967). 
In conclusion, Altura's view im-
plies that antihistamines, a large 
group of variously-structured com-
pounds selected solely for ability to 
block histamine actions, also in-
variably possess a histamine-unre-
lated property of direct vasocon-
striction. If true, this would be a 
most remarkable coincidence. The 
conservative interpretation suggests 
that microvascular smooth muscle 
cells are under the continual dilator 
influence of histamine produced 
within them. 
Summary 
Evidence based on recent re-
search on histamine metabolism 
supports the following views: 
(a) Microvascular smooth muscle 
cells are under the continuous 
dilator influence of minute 
quantities of histamine formed 
within them. 
(b) This histamine is produced by 
action of an inducible form of 
histidine decarboxylase and 
acts on intracellular "intrinsic" 
receptors. 
( c) Autonomous dilator activities 
of the microcirculation, e.g., 
vasomotion, reactive and post-
exercise hyperemia and auto-
regulation, may all involve this 
intrinsic dilator. 
( d) Adaptation of the microcir-
culation to environmental 
changes may be accomplished, 
in part, by readjustment of the 
rate of histamine formation. 
( e) Drastic stimuli which cause a 
marked increase in histamine 
output, locally or systemically, 
may lead to the microvascular 
changes in inflammation and 
shock, respectively. 
(f) The proposed intrinsic dilator 
mechanism permits a reason-
able unification of the major 
effects of the glucocorticoids 
in terms of a primary interac-
tion of hormone molecules 
with microvascular smooth 
muscle cells. 
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